Global Beta-Nicotinamide Mononucleotide (NMN) Market Trends and Forecast Report 2022: by Players, Types, Applications and Regions

QY Research released a latest market research report on the Global Beta-Nicotinamide Mononucleotide (NMN) market, which is segmented by region (country), company and by Application. Players, stakeholders, and other participants in the global Beta-Nicotinamide Mononucleotide (NMN) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application of Global Beta-Nicotinamide Mononucleotide (NMN) market.

 

Summary

The global Beta-Nicotinamide Mononucleotide (NMN) market is valued at US$ 256.74 million in 2021. The market size will reach US$ 1075.42 million by the end of 2028, growing at a CAGR of 20.23% during 2022-2028.

 

Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click 

https://us.qyresearch.com/reports/366851/beta-nicotinamide-mononucleotide-nmn

 

The report mentions the prominent market player consisting of:

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

 

Beta-Nicotinamide Mononucleotide (NMN) Market Segment by Type

Content ≥98%

Content <98%

 

Beta-Nicotinamide Mononucleotide (NMN) Market Segment by Application

Health Care Products

Cosmetics

Others

 

The report on the Beta-Nicotinamide Mononucleotide (NMN) market covers the following region (country) analysis:

North America

U.S.

Canada

 

Asia-Pacific

China

Japan

Korea

India

Australia

Southeast Asia

 

Europe

Germany

France

U.K.

Italy

Russia

 

Latin America

Mexico

Brazil

Argentina

 

Middle East and Africa

Middle East

Africa

 

The Goal of the Report

To study and analyze the global Beta-Nicotinamide Mononucleotide (NMN) consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.

To understand the structure of Beta-Nicotinamide Mononucleotide (NMN) market by identifying its various subsegments.

Focuses on the key global Beta-Nicotinamide Mononucleotide (NMN) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Beta-Nicotinamide Mononucleotide (NMN) with respect to individual growth trends, prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).

To project the consumption of Beta-Nicotinamide Mononucleotide (NMN) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

 

Table of Contents

1 STUDY COVERAGE 1
1.1 Beta-Nicotinamide Mononucleotide (NMN) Product Introduction 1
1.2 Market by Type 1
1.3 Market by Application 2
1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application 2
1.3.2 Health Care Products 3
1.3.3 Cosmetics 4
1.4 Study Objectives 4
1.5 Years Considered 5

2 EXECUTIVE SUMMARY 6
2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2017-2028 6
2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts 2017-2028 7
2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region: 2017 VS 2022 VS 2028 8
2.4 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales 9
2.4.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2017-2022) 9
2.4.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Sales (2023-2028) 10
2.5 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue 12
2.5.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2017-2022) 12
2.5.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Regions by Revenue (2023-2028) 12
2.6 North America 13
2.7 Europe 14
2.8 Asia-Pacific 15
2.9 Latin America 16
2.10 Middle East and Africa 17

3 COMPETITION BY MANUFACTURERS 19
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers 19
3.1.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Sales (2017-2022) 19
3.1.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Sales (2017-2022) 20
3.1.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Sales in 2021 21
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers 21
3.2.1 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers by Revenue (2017-2022) 21
3.2.2 Global Top Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Share by Revenue (2017-2022) 22
3.2.3 Global Top 5 Companies by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2021 23
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers 23
3.4 Analysis of Competitive Landscape 24
3.4.1 Manufacturers Market Concentration Ratio (CR5) 24
3.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 24
3.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Geographical Distribution 25
3.5 Mergers & Acquisitions, Expansion Plans 26

4 MARKET SIZE BY TYPE 27
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type 27
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Type (2017-2022) 27
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Type (2023-2028) 27
4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2017-2028) 27
4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type 28
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Type (2017-2022) 28
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Type (2023-2028) 29
4.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2017-2028) 29
4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type 30
4.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2017-2022) 30
4.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Type (2023-2028) 30

5 MARKET SIZE BY APPLICATION 32
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application 32
5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Sales by Application (2017-2022) 32
5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Sales by Application (2023-2028) 32
5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2017-2028) 33
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application 34
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Historical Revenue by Application (2017-2022) 34
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Revenue by Application (2023-2028) 34
5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2017-2028) 34
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application 36
5.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2017-2022) 36
5.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Price Forecast by Application (2023-2028) 36

6 NORTH AMERICA 37
6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 37
6.1.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 37
6.1.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 38
6.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 39
6.2.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 39
6.2.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 40
6.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 42
6.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 42
6.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 43
6.3.3 U.S. 44
6.3.4 Canada 45

7 EUROPE 46
7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 46
7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 46
7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 47
7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 48
7.2.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 48
7.2.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 49
7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 51
7.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 51
7.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 52
7.3.3 Germany 54
7.3.4 France 55
7.3.5 U.K. 55
7.3.6 Italy 56
7.3.7 Russia 56

8 ASIA PACIFIC 57
8.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 57
8.1.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 57
8.1.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 58
8.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 59
8.2.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 59
8.2.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 60
8.3 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region 62
8.3.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2017-2028) 62
8.3.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2017-2028) 63
8.3.3 China 65
8.3.4 Japan 66
8.3.5 Korea 67
8.3.6 India 68
8.3.7 Australia 69
8.3.8 Southeast Asia 70

9 LATIN AMERICA 71
9.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 71
9.1.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 71
9.1.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 72
9.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 73
9.2.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 73
9.2.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 74
9.3 Latin America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 76
9.3.1 Latin America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 76
9.3.2 Latin America Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 77
9.3.3 Mexico 79
9.3.4 Brazil 80
9.3.5 Argentina 81

10 MIDDLE EAST AND AFRICA 82
10.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type 82
10.1.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2017-2028) 82
10.1.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2017-2028) 83
10.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application 84
10.2.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2017-2028) 84
10.2.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2017-2028) 85
10.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country 87
10.3.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2017-2028) 87
10.3.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2017-2028) 88
10.3.3 Middle East 89
10.3.4 Africa 90

11 CORPORATE PROFILE 91
11.1 GeneHarbor 91
11.1.1 GeneHarbor Corporation Information 91
11.1.2 GeneHarbor Overview 91
11.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 92
11.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 92
11.1.5 GeneHarbor Recent Developments 93
11.2 Herbalmax 93
11.2.1 Herbalmax Corporation Information 93
11.2.2 Herbalmax Overview 93
11.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 94
11.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 94
11.3 Genex Formulas 95
11.3.1 Genex Formulas Corporation Information 95
11.3.2 Genex Formulas Overview 95
11.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 96
11.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 96
11.4 Shinkowa Pharmaceutical 97
11.4.1 Shinkowa Pharmaceutical Corporation Information 97
11.4.2 Shinkowa Pharmaceutical Overview 97
11.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 98
11.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 98
11.4.5 Shinkowa Pharmaceutical Recent Developments 98
11.5 Maac10 Formulas 99
11.5.1 Maac10 Formulas Corporation Information 99
11.5.2 Maac10 Formulas Overview 99
11.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 100
11.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 100
11.6 EffePharm 101
11.6.1 EffePharm Corporation Information 101
11.6.2 EffePharm Overview 101
11.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 101
11.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 102
11.7 Bontac 102
11.7.1 Bontac Corporation Information 102
11.7.2 Bontac Overview 103
11.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 103
11.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 104
11.7.5 Bontac Recent Developments 104
11.8 CELFULL 104
11.8.1 CELFULL Corporation Information 104
11.8.2 CELFULL Overview 105
11.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 105
11.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 105
11.9 Kingdomway 106
11.9.1 Kingdomway Corporation Information 106
11.9.2 Kingdomway Overview 106
11.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Price, Revenue and Gross Margin (2017-2022) 107
11.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Model Numbers, Pictures, Descriptions and Specifications 108

12 VALUE CHAIN AND SALES CHANNELS ANALYSIS 109
12.1 Beta-Nicotinamide Mononucleotide (NMN) Value Chain Analysis 109
12.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials 109
12.2.1 Key Raw Materials 109
12.2.2 Raw Materials Key Suppliers 109
12.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process 110
12.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing 110
12.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels 110
12.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors 112
12.5 Beta-Nicotinamide Mononucleotide (NMN) Customers 113

13 MARKET DRIVERS, OPPORTUNITIES, CHALLENGES AND RISKS FACTORS ANALYSIS 114
13.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends 114
13.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers 114
13.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges 115
13.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints 115

14 KEY FINDINGS IN THE GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) STUDY 116

15 APPENDIX 117
15.1 Research Methodology 117
15.1.1 Methodology/Research Approach 117
15.1.2 Data Source 120
15.2 Author Details 122

 

For More Information About This Report, Please Enter:

https://us.qyresearch.com/reports/366851/beta-nicotinamide-mononucleotide-nmn

Any doubts and questions will be welcome.

 

About Us:

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world,QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.

 

Contact Us

QY Research

E-mail: [email protected]

Tel: +1-626-842-1666(US)   +852-5808-0956 (HK)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

Website: https://us.qyresearch.com

Leave a comment

Your email address will not be published. Required fields are marked *